Racura Oncology LtdASX: RAC

Racura Successfully PK Bridges RC110 RC220

· Issued by Racura Oncology Ltd via ASX

Filed with ASX · · 5 pages · English

Release

ASX Announcement Racura Successfully Demonstrates Pharmacokinetic Equivalence of RC110 & RC220 § A nonclinical pharmacokinetic bridging study has found that RC220 and the earlier RC110 formulation of (E,E)-bisantrene deliver equivalent systemic drug exposure § Ratios of peak and total drug...

Racura Oncology Ltd on 6ix

In the deck

Earlier from Racura Oncology

Later from Racura Oncology

All Racura Oncology news releases